Trial Profile
A phase II study to determine the efficacy and safety of lipoplatin and gemcitabine in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Jan 2017
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 04 Jan 2017 New trial record